62469-61-8

• 常用中文名：11-Chlorodibenzo[b,f][1,4]oxazepine
• 常用英文名：11-Chlorodibenzo[b,f][1,4]oxazepine
• CAS号：62469-61-8
• 分子式：C₁₃H₈ClNO
• 分子量：229.66200
• 发布时间：2016-12-21 02:53:46
• 更新时间：2025-09-17 09:51:31

名称

• 英文名: 6-chlorobenzo[b][1,4]benzoxazepine
• 英文别名: 11-Chlordibenzo<b,f>-1,4-oxazepin; 11-chloro-dibenz<b,f><1,4>oxazepine; 11-Chlorodibenzo[b,f][1,4]oxazepine

物化性质

• 分子式: C₁₃H₈ClNO
• 分子量: 229.66200
• 精确质量: 229.02900
• PSA: 21.59000
• LogP: 3.54500

安全

• 海关编码: 2934999090

合成路线

3158-85-8 ~86% 62469-61-8

文献：ENVIVO PHARMACEUTICALS, INC.; METHYLGENE INC. Patent: WO2009/137499 A1, 2009 ; Location in patent: Page/Page column 60 ; WO 2009/137499 A1

3158-85-8 10025-87-3 ~87% 62469-61-8

文献：METHYGENE INC.; EN VIVO PHARMACEUTICALS, INC. Patent: WO2008/55068 A2, 2008 ; Location in patent: Page/Page column 102 ; WO 2008/055068 A2

92164-06-2 ~% 62469-61-8

文献：Wagh; Patil; Jain; Harak Heterocyclic Communications, 2007 , vol. 13, # 2-3 p. 165 - 172

119-36-8 ~% 62469-61-8

文献：Wagh; Patil; Jain; Harak Heterocyclic Communications, 2007 , vol. 13, # 2-3 p. 165 - 172

666818-15-1 ~% 62469-61-8

文献：Smits, Rogier A.; Lim, Herman D.; Stegink, Bart; Bakker, Remko A.; De Esch, Iwan J. P.; Leurs, Rob Journal of Medicinal Chemistry, 2006 , vol. 49, # 15 p. 4512 - 4516

393-52-2 ~% 62469-61-8

文献：Smits, Rogier A.; Lim, Herman D.; Stegink, Bart; Bakker, Remko A.; De Esch, Iwan J. P.; Leurs, Rob Journal of Medicinal Chemistry, 2006 , vol. 49, # 15 p. 4512 - 4516

445-29-4 ~% 62469-61-8

文献：Smits, Rogier A.; Lim, Herman D.; Stegink, Bart; Bakker, Remko A.; De Esch, Iwan J. P.; Leurs, Rob Journal of Medicinal Chemistry, 2006 , vol. 49, # 15 p. 4512 - 4516

171103-28-9 ~% 62469-61-8

文献：Wagh; Patil; Jain; Harak Heterocyclic Communications, 2007 , vol. 13, # 2-3 p. 165 - 172

上下游产品

上游产品  7
3158-85-8 10025-87-3 119-36-8 666818-15-1
393-52-2 445-29-4 171103-28-9
下游产品  3
2868-49-7 2770-17-4 21636-40-8

海关

海关编码	2934999090
中文概述	2934999090. 其他杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素	品名, 成分含量, 用途
Summary	2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%